A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers

Inclusion Criteria: * Male or female subjects, considered generally healthy upon completion of medical history, physical examination and biochemical investigations as judged by the Investigator. * Age ≥ 18 and ≤ 64 years, both inclusive. * Body Mass Index (BMI) between 18.5 and 28.0 kg∙m-2, both inclusive. * Fasting Plasma Glucose (FPG) ≤ 5.6 mmol/L (100 mg/dL). * Signed and dated informed consent obtained before any trial-related activities, i.e. any procedures that would not have been performed during normal management of the subject). Exclusion Criteria: * Known or suspected hypersensitivity to trial product(s) or related products. * Receipt of any investigational medicinal product within 3 months before randomisation in this trial.